Jan 11 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Nov 30, 2018 Nov 30, 2017 May 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 298.37 270.84 610.00
(+10.2 pct) (+9.6 pct) (+9.3 pct)
Operating 12.33 10.29 23.00
(+19.8 pct) (-13.4 pct) (+1.1 pct)
Recurring 13.50 11.59 25.50
(+16.5 pct) (-11.1 pct) (+1.0 pct)
Net 9.01 7.78 17.65
(+15.7 pct) (-10.4 pct) (+0.1 pct)
EPS 454.83 yen 393.00 yen 891.43 yen
Ann Div 90.00 yen 90.00 yen
-Q2 div 45.00 yen 45.00 yen
-Q4 div 45.00 yen 45.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T